Lisa T. Dooley

机构：PRX Research

发表论文 16 篇 · 总被引 7897 次 · h-index 14

代表论文

• Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) (2008 · The Lancet · 被引 1875)
• Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) (2008 · The Lancet · 被引 1365)
• Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial (2005 · The Lancet · 被引 1046)
• Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis (2010 · New England Journal of Medicine · 被引 858)
• A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis (2007 · New England Journal of Medicine · 被引 808)
• Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial (2004 · Journal of the American Academy of Dermatology · 被引 583)